Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subscribe to Newsletter

Bruce Levine

The Power List 2020 – Advanced Medicine


Barbara and Edward Netter Professor in Cancer Gene Therapy at the University of Pennsylvania

As ISCT’s president elect, Levine has been vocal about the need to address the talent bottleneck in advanced medicine. “There is a critical shortage of talent at all levels, from technicians and development scientists, manufacturing and analytics staff, to clinical expertise in the management of cell and gene patients,” he says. “There is a huge need for more cell and gene specific education programs as scientific and clinical development has outpaced the training of new professionals to meet the demand.” Levine also asks how regulations and policies can be revised and adapted to allow the advancement of cells and engineered cells producing medicines. “For countries that have a limited regulatory framework in place for advanced therapies, what is the best model of flexibility that protects patients while allowing investigation and subsequent approvals based on the best scientific and clinical evidence to proceed?” he asks.


Part of the Power List 2020

The Power List 2020

Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.

Go to The Power List 2020

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register